DiNovA Medtech
Hangzhou
About DiNovA Medtech
DiNovA Medtech develops vascular intervention technology for the treatment of aneurysm. Weiqiang Medical Technology specializes in researching and developing innovative vascular dilation products including aortic stent graft system, intraoperative stent system, peripheral vascular stent, and other supporting medical devices, aiming to provide advanced, effective medical solutions for the complicated treatments of various aortic vascular diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $41.6M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2020)
- Website: dinovamedtech.com
Industries & Categories
Health Care, Medical, Medical Device, Sales, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dinova-medtech-135286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.